CIK: 0001232621 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 16, 2016
Total Value ($000): $219,600 (87.7% shares, 12.3% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 5,190,837 | $98,574 | 44.9% | $12.86 | +53.4% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 3,052,130 | $63,820 | 29.1% | $14.80 | — | COM | 503459604 |
| — | OPKO HEALTH INC | 14,000,000 | $21,833 | 9.9% | $1.47 | — | DEBT 3.0% 2/1/33 | 68375NAB9 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 90,215 | $7,441 | 3.4% | $62.32 | +30.6% | COM | 09061G101 |
| — | MERRIMACK PHARMACEUTICALS INC | 3,500,000 | $5,233 | 2.4% | $1.36 | — | NOTE 4.5% 7/15/20 | 590328AA8 |
| SRPT | SAREPTA THERAPEUTICS INC | 250,000 | $4,880 | 2.2% | $17.47 | 0.0% | COM | 803607100 |
| BABA | ALIBABA GROUP HLDG LTD | 60,000 | $4,742 | 2.2% | $79.03 | — | SPONSORED ADS | 01609W102 |
| OPK | OPKO HEALTH INC | 350,000 | $3,637 | 1.7% | $9.14 | 0.0% | COM | 68375N103 |
| — | NEKTAR THERAPEUTICS | 260,000 | $3,575 | 1.6% | $13.75 | — | COM | 640268108 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 460,000 | $2,424 | 1.1% | $6.12 | 0.0% | COM | 45665G303 |
| BCRX | BIOCRYST PHARMACEUTICALS | 430,000 | $1,217 | 0.6% | $4.43 | 0.0% | COM | 09058V103 |
| — | LIPOCINE INC | 100,000 | $1,015 | 0.5% | $10.15 | — | COM | 53630X104 |
| — | ATYR PHARMA INC | 190,000 | $749 | 0.3% | $3.94 | — | COM | 002120103 |
| — | IGNYTA INC | 40,000 | $271 | 0.1% | $6.78 | — | COM | 451731103 |
| — | CELLDEX THERAPEUTICS INC | 50,000 | $189 | 0.1% | $3.78 | — | COM | 15117B103 |